Levosimendan in Patients With Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery On Cardiopulmonary Bypass
Status:
Completed
Trial end date:
2016-11-01
Target enrollment:
Participant gender:
Summary
A study to evaluate levosimendan compared with placebo in reducing the composite event rate
of all-cause death, perioperative MI, need for new dialysis, or use of mechanical assist
(IABP, LVAD or ECMO) in subjects with reduced ejection fraction undergoing cardiac surgery on
cardiopulmonary bypass (CPB).